To get a sense of who is truly in control of Cartesian Therapeutics, Inc. (NASDAQ:RNAC), it is important to understand the ownership structure of the business. We can see that individual insiders own ...

LLDAS response rate observed in patients with SLE who received Descartes-08 in Phase 2 open-label trial reaching Month 3 follow-up (n=3) Disease remission reported as DORIS response seen in 2 out of 3 ...

Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Preliminary data from Phase 2 trial of Descartes-08 in systemic ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from ...

FREDERICK, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...

For full chart and more detailed rules, visit https://yobang.tencentmusic.com/ For 2024 Year-End chart, visit https://yobang.tencentmusic.com/chart-h5/annual-report ...

The Carolina Panthers got a little healthier prior to Sunday's 13-6 win over the New York Jets. But they didn't come out of the triumph entirely clean, as the outing yielded a rough injury to a pretty ...

Cleveland Browns quarterback Shedeur Sanders moved up the team's depth chart after the Joe Flacco trade a couple weeks ago, but it doesn't sound like he's much closer to receiving playing time.

In Martin Wolf’s column on October 15, the chart titled “Measures of uncertainty have fallen from their peaks” incorrectly transposed the lines for trade and economic policy uncertainty. Trade policy ...